Human medicines European public assessment report (EPAR): Aripiprazole Zentiva, aripiprazole, Date of authorisation: 25/06/2015, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation: 19/02/2018, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Rezzayo, rezafungin, Date of authorisation: 22/12/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 11, Status: Authorised

Maximum residue limits (MRLs): Questions and answers

Substances exempt from maximum residue limit evaluation

Submitting a maximum residue limit application

Establishing maximum residue limits for veterinary medicines

Maximum residue limits (MRL)